Paper40700321
Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic.
Garduño-Orbe B and 7 others. Infect Dis Rep, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic. Papers, record 40700321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40700321
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39708059 | Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States. | Infect Dis Ther | 2025 | https://conductscience.org/library/papers/39708059 | PubMed |
| 2 | 38505296 | Real-world Effectiveness of mRNA COVID-19 Vaccines Among US Nursing Home Residents Aged ≥65 Years in the Pre-Delta and High Delta Periods. | Open Forum Infect Dis | 2024 | https://conductscience.org/library/papers/38505296 | PubMed |
| 3 | 32320003 | Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. | JAMA | 2020 | https://conductscience.org/library/papers/32320003 | PubMed |
| 4 | 34035524 | Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. | Nat Metab | 2021 | https://conductscience.org/library/papers/34035524 | PubMed |
| 5 | 33479118 | Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. | Science | 2021 | https://conductscience.org/library/papers/33479118 | PubMed |
| 6 | 35513438 | Beyond comorbidities, sex and age have no effect on COVID-19 health care demand. | Sci Rep | 2022 | https://conductscience.org/library/papers/35513438 | PubMed |
| 7 | 35717236 | Barriers to COVID-19 vaccination among older adults in Mexico City. | Int J Equity Health | 2022 | https://conductscience.org/library/papers/35717236 | PubMed |
| 8 | 36879082 | Functional outcomes in post Covid-19 patients with persistent dyspnea: multidisciplinary approach. | Int J Cardiovasc Imaging | 2023 | https://conductscience.org/library/papers/36879082 | PubMed |
| 9 | 40014628 | Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025. | MMWR Morb Mortal Wkly Rep | 2025 | https://conductscience.org/library/papers/40014628 | PubMed |
| 10 | 32967006 | SARS-CoV-2 vaccines in development. | Nature | 2020 | https://conductscience.org/library/papers/32967006 | PubMed |
| 11 | 35099875 | Acceptance, refusal and hesitancy of Covid-19 vaccination in Mexico: Ensanut 2020 Covid-19. | Salud Publica Mex | 2021 | https://conductscience.org/library/papers/35099875 | PubMed |
| 12 | 34320281 | Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34320281 | PubMed |
| 13 | 33692570 | COVID-19 and liver disease: mechanistic and clinical perspectives. | Nat Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33692570 | PubMed |
| 14 | 33301246 | Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. | N Engl J Med | 2020 | https://conductscience.org/library/papers/33301246 | PubMed |
| 15 | 34461056 | Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/34461056 | PubMed |
| 16 | 37080227 | COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint. | Lancet Respir Med | 2023 | https://conductscience.org/library/papers/37080227 | PubMed |
| 17 | 17167474 | Inflammation and metabolic disorders. | Nature | 2006 | https://conductscience.org/library/papers/17167474 | PubMed |
| 18 | 34192737 | Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. | Nature | 2021 | https://conductscience.org/library/papers/34192737 | PubMed |
| 19 | 33444545 | SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. | Lancet Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33444545 | PubMed |
| 20 | 33306989 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. | Lancet | 2021 | https://conductscience.org/library/papers/33306989 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41773107 | The Impact of Disease-Modifying Antirheumatic Drugs on In-Hospital Outcomes of Patients With COVID-19: A Retrospective Cohort Study and Literature Review. | Cureus | 2026 | https://conductscience.org/library/papers/41773107 | PubMed |
| 41441721 | Socioeconomic Barriers to COVID-19 Booster Vaccination in Southern Italy: A Retrospective Study to Evaluate Association with the Social and Material Vulnerability Index in Apulia. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41441721 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40700321
GET https://conductscience.org/api/papers/v1/40700321/references?page=2